Phunware Inc reported a 76% revenue increase to $0.8 million in Q2, driven by its AI-led growth strategy under new CEO Dmitry Kroshka. The company is transforming into an AI-enabled guest intelligence platform, focusing on hospitality and expanding into healthcare and other physical venues. With $92.1 million in cash and no debt, Phunware is investing heavily in product development and sales, including new AI products like AI Concierge. Despite a wider net loss due to increased spending, the company maintains a strong customer retention rate above 95% and plans to enhance investor engagement while pursuing long-term growth across multiple industries.
Genasys reported a Q3 2026 revenue drop to $7.3M due to supply-chain issues and a work suspension, not demand loss. Despite this, gross margin improved to 57.1% and operating loss narrowed to $4M, showing better efficiency. An analyst raised the pric...
Definitive Healthcare Corp. stands out with a remarkable Return on Invested Capital (ROIC) of 41.44%, significantly exceeding its Weighted Average Cost of Capital (WACC) of 5.78%. This means the company generates over seven times the value for every ...
Industrial Alliance Securities raised OptimumBank Holdings' price target from $7.00 to $11.00, signaling a 15.24% potential upside. The bank shows strong financial health with a 2.04% ROAA, 20.34% ROAE, and a 4.57% net interest margin. Its loans grew...
Industrial Alliance Securities lowered Abeona Therapeutics' price target from $20 to $15 following a 14% stock drop after the company reported Q2 revenues of $11.4 million, missing analyst expectations. The company faces operational challenges with i...
Inovio Pharmaceuticals is progressing its DNA medicine pipeline with its lead candidate INO-3107 for Recurrent Respiratory Papillomatosis under FDA accelerated review, targeting a decision by October 30, 2026. The company raised $18.3 million in fund...
